---
figid: PMC11781520__ijmm-55-03-05494-g00
figtitle: MiR-29s in the signalling of innate immunity
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11781520
filename: ijmm-55-03-05494-g00.jpg
figlink: /pmc/articles/PMC11781520/figure/F1/
number: F1
caption: Mechanisms of miR-29s in the signalling of innate immunity. (A) Within the
  TLR signalling pathway, miR-29a interacts with TLR7 and TLR8, inhibiting the binding
  of MyD88 to TLR7/TLR8 and subsequent signal transduction. Additionally, miR-29s
  directly target and inhibit DNMT, B7-H3 and AKT1. The reduction of DNMT promotes
  the expression of COX2, which in turn facilitates the binding of NFκB to transcriptional
  genes. AKT1 binds directly to NFκB, enhancing the binding of NFκB to transcriptional
  genes. TLR2, TLR5 and NOD2 stimulate the formation of miR-29s, which can then directly
  target and reduce inflammatory cytokines such as IL12 and IL23. (B) Within the IFN
  signalling pathway, miR-29s directly target and reduce the translation of IFNαR
  and IFN-γ. Downstream of IFNR, miR-29s target the STAT6 inhibitor SOCS-1, increasing
  the levels of STAT6. Furthermore, miR-29c targets STAT3. miR, microRNA; TLR, Toll-like
  receptor; MyD88, DNMT, DNA methyltransferase; COX2, cyclooxygenase-2; NOD2, nucleotide
  binding oligomerization domain containing 2; IFN, interferon; IFNR, interferon receptor;
  SOCS-1, suppressor of cytokine signalling 1; P, phosphorus; ISRE, interferon stimulated
  response element; GAS, gamma-activated sequence
papertitle: Recent insights and perspectives into the role of the miRNA-29 family
  in innate immunity (Review)
reftext: Xing-Chen Yao, et al. Int J Mol Med. 2025 Mar;55(3).
year: '2025'
doi: 10.3892/ijmm.2025.5494
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: Spandidos Publications
keywords: microRNA-29 | innate immunity | innate immunity cells | virus
automl_pathway: 0.9346581
figid_alias: PMC11781520__F1
figtype: Figure
redirect_from: /figures/PMC11781520__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11781520__ijmm-55-03-05494-g00.html
  '@type': Dataset
  description: Mechanisms of miR-29s in the signalling of innate immunity. (A) Within
    the TLR signalling pathway, miR-29a interacts with TLR7 and TLR8, inhibiting the
    binding of MyD88 to TLR7/TLR8 and subsequent signal transduction. Additionally,
    miR-29s directly target and inhibit DNMT, B7-H3 and AKT1. The reduction of DNMT
    promotes the expression of COX2, which in turn facilitates the binding of NFκB
    to transcriptional genes. AKT1 binds directly to NFκB, enhancing the binding of
    NFκB to transcriptional genes. TLR2, TLR5 and NOD2 stimulate the formation of
    miR-29s, which can then directly target and reduce inflammatory cytokines such
    as IL12 and IL23. (B) Within the IFN signalling pathway, miR-29s directly target
    and reduce the translation of IFNαR and IFN-γ. Downstream of IFNR, miR-29s target
    the STAT6 inhibitor SOCS-1, increasing the levels of STAT6. Furthermore, miR-29c
    targets STAT3. miR, microRNA; TLR, Toll-like receptor; MyD88, DNMT, DNA methyltransferase;
    COX2, cyclooxygenase-2; NOD2, nucleotide binding oligomerization domain containing
    2; IFN, interferon; IFNR, interferon receptor; SOCS-1, suppressor of cytokine
    signalling 1; P, phosphorus; ISRE, interferon stimulated response element; GAS,
    gamma-activated sequence
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR2
  - TLR5
  - IL12A
  - IL12B
  - IL37
  - IL23A
  - NOD2
  - CD276
  - AKT1
  - DNMT1
  - DNMT3A
  - DNMT3B
  - DNMT3L
  - IFN1@
  - IFNA1
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNB1
  - IFNAR1
  - IFNAR2
  - COX2
  - PTGS2
  - MTCO2P12
  - TLR7
  - TLR8
  - MYD88
  - MIR29A
  - NFKB1
  - IFNK
  - IFNW1
  - IL6
  - IL1B
  - TNF
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - CCL2
  - CD80
  - CD86
  - TYK2
  - STAT2
  - JAK1
  - STAT1
  - SOCS1
  - STAT6
  - JAK2
  - IRF9
  - SOAT1
  - STAT3
  - STAT4
  - STAT5A
  - STAT5B
  - MIR29C
  - GAST
  - GALNS
  - PAGR1
  - Nucleus
---
